![](/img/cover-not-exists.png)
Incidence rate and risk factors for thyroid dysfunction during recombinant interleukin-2 therapy in advanced malignancies
Vialettes, B., Guillerand, M. A., Viens, P., Stoppa, A.-M., Baume, D., Sauvan, R., Pasquier, J., Marco, M. S., Olive, D., Maraninchi, D.Volume:
129
Language:
english
Journal:
European Journal of Endocrinology
DOI:
10.1530/acta.0.1290031
Date:
July, 1993
File:
PDF, 857 KB
english, 1993